Abstract 16967: Predictors for Recovery of Ejection Fraction in Urban Cohort of Patients With Heart Failure

Autor: Inna Bukharovich, Jonathan Francois, Christian Abrahim, Romy Rodriguez Ortega, Mohammed Al-Sadawi
Rok vydání: 2020
Předmět:
Zdroj: Circulation. 142
ISSN: 1524-4539
0009-7322
DOI: 10.1161/circ.142.suppl_3.16967
Popis: Introduction: Despite the clinical and economic impact of heart failure with reduced ejection fraction (HFrEF), understanding surrounding factors associated with resolution of ejection fraction (EF) as well as its prognostic value, remains elusive. Hypothesis: Predictors for Recovery of EF may differ in African Americans compared to the general population. Methods: We conducted a single center retrospective chart review on patients following up in the adult heart failure clinic at our inner city hospital located in Central Brooklyn. Chart review of 312 patients was performed and data including, demographics, comorbidities, medications and echocardiographic parameters. Patients not on an ACE inhibitor or angiotensin receptor blocker (ARB) were excluded as were those with a diagnosis of heart failure with preserved ejection fraction. Results: Of 312 patients identified, 158 (50.6%) were male and 289 (92.6%) identified as African in ancestry. Mean time since diagnosis was 86.2 months (SEM 4.9). There were 113 (36.2%) patients who had recovery of ejection fraction to greater than 50%. There were 59 patients on Angiotensin Receptor-Neprilysin Inhibitor (ARNI) therapy. Patients on ARNI were less likely to have ventricular recovery with an Odds Ratio (OR) of 0.484. The duration of heart failure in the patients with ARNI was significantly less than those on ACE/ARB therapy, 29.15 months versus 99.49 months respectively (2 tailed P value for difference of means Conclusion: In our predominantly African American cohort of patients, key GDMT medication including ARNI, Beta blockers and aldosterone antagonists reduced the odds of EF recovery.
Databáze: OpenAIRE